Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Translational medicine Stories

2010-10-19 05:00:00

REDWOOD CITY, Calif., Oct. 19 /PRNewswire/ -- Ingenuity® Systems, the leading provider of information solutions for life science researchers, and TransMed Systems, a translational medicine software and services company, today announced an integration between IPA® software and XB Bio-Integration Suite (XB-BIS). Researchers can now easily take pre-clinical and clinical data that is managed and statistically analyzed by XB-BIS, directly into...

2010-08-24 14:00:00

COLUMBIA, Md., Aug. 24 /PRNewswire/ -- Catholic Health Initiatives' (CHI) Institute for Research and Innovation's Center for Translational Research and BioFortis, Inc. have announced a joint strategic partnership to focus on CHI's vision in personalized healthcare initiatives for community hospitals across their system. CHI's Center for Translational Research (CTR) is a clinical R&D and molecular diagnostics laboratory that supports the progressive advancement, commercialization, and...

2010-08-16 05:00:00

VANCOUVER, Aug. 16 /PRNewswire/ - Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development. The ISCT Industry Task Force (ITF), comprising these major corporations along with internationally renowned clinicians and academics in cell therapy...

2010-07-15 14:56:20

Now that scientists have learned so much about aging through laboratory studies, it's time to translate those findings into medicines that can benefit our aging population. That was the message delivered by a panel of 10 preeminent aging experts that included Jan Vijg, Ph.D., chair of genetics and the Lola and Saul Kramer Chair in Molecular Genetics at Albert Einstein College of Medicine of Yeshiva University. The expert panel was convened by the LifeStar Institute, a nonprofit organization...

2010-04-29 07:00:00

CHICAGO, April 29 /PRNewswire/ -- Scotland will showcase the talent and collaborative spirit that has attracted many of the world's leading pharma and biotech companies to its shores at this year's BIO conference, May 3-6 in Chicago. Heading into the conference, Scottish Enterprise and sector leaders believe Scottish research and the nation's unique integrated industry approach will continue to fuel life sciences growth, particularly in scientific infrastructure, stem cell therapeutics...

2009-10-26 14:44:00

NEW YORK, Oct. 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Approaches to Reducing Phase II Attrition http://www.reportlinker.com/p0156562/Reportlinker-Adds-Approaches-to-Reducing-Phase-II-Attrition.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Phase II is the critical development stage in which most clinical attrition occurs. This report focuses on approaches to improving...

2009-09-17 07:30:00

Council for American Medical Innovation Brings Together Policy Experts for 'Translational Research: From Bench to Bedside,' the Second in a Series of Briefings About Achieving 'Recovery Through Discovery' WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- Experts gathered on Capitol Hill today to address the impact of policies related to translational research and U.S. medical innovation. The briefing, titled Translational Research: From Bench to Bedside, was sponsored by the Council for...

2009-09-14 07:00:00

Briefing is the second in a three-part series on "Achieving Recovery Through Discovery" WASHINGTON, Sept. 14 /PRNewswire-USNewswire/ -- The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics. The Council believes a...

2008-09-23 06:00:32

WELLESLEY, Mass., Sept. 23 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that the Mt. Sinai Services unit of the Mt. Sinai Hospital in Toronto, Canada, has become an authorized provider of gene-expression services using Xceed's Ziplex System. The Mt. Sinai Hospital reference laboratory is a CLIA laboratory, accredited by the College of American Pathologists, and ISO 9001-certified by the Ontario...

2008-08-05 15:01:02

Dr. LingSing K. Chen has been chosen to head the new Translational Medicine department at QPS, a leading provider of research services for the pharmaceutical industry. "In its Critical Path Initiative, the FDA identified -- correctly, we believe -- the need for this country to make significant improvements to the process under which new drugs are developed," said Dr. Ben Chien, QPS president and CEO. "By adding a department of Translational Medicine, we hope to play an integral role in the...